Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v2.4.0.8
Consolidated Balance Sheets (USD $)
Dec. 31, 2012
Dec. 31, 2011
ASSETS    
Cash $ 159,297 $ 7,946
Other receivables 7,332 718
Total current assets 166,629 8,664
Long-term Investment (Note 5 and 11)      
TOTAL ASSETS 166,629 8,664
LIABILITIES AND STOCKHOLDERS' DEFICIENCY    
Other payable 62,641   
Amount due to director (Note 4) 49,767   
Short term loan (Note 6 and 11) 79,282   
Accrued liabilities 55,830 28,739
TOTAL LIABILITIES 247,520 28,739
Related Party Transactions (Note 4)      
Subsequent Events (Note 11)      
STOCKHOLDERS' DEFICIENCY    
Capital Stock Series C Voting Preferred stock, $0.001 par value, 5,000,000 shares authorized, 28,092 shares issued and outstanding as of December 31, 2012 and nil shares issued and outstanding as of December 31, 2011 (Note 9) 28   
Common stock, $0.001 par value, 100,000,000 shares authorized and 24,683,285 shares issued and outstanding as of December 31, 2012, and 18,553,778 shares issued and outstanding as of December 31, 2011 (Note 9) 24,684 18,554
Additional Paid-In Capital (Note 9) 5,790,663 5,428,460
Deficit (5,897,879) (1,305,454)
Deficit accumulated during the development stage    (4,161,635)
Foreign currency translation adjustment 1,613   
TOTAL STOCKHOLDER' S DEFICIENCY (80,891) (20,075)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY $ 166,629 $ 8,664